Stocks TelegraphStocks Telegraph
Stock Ideas

FENC Stock Performance and Key Statistics

NASDAQ : FENC

Fennec Pharmaceuticals

$10.31
0.06+0.59%
At Close 4:00 PM
64.34
BESG ScoreESG Rating

stock performance chart

FENC Fundamental Analysis

Based on recent data, Fennec Pharmaceuticals Inc. (FENC) shows an Average True Range (ATR) of 0.41 and an Enterprise Value of 262.18M. Its average trading volume over the past 3 months is 273.49K, indicating liquidity. These fundamental metrics provide insight into FENC's underlying financial health and market activity.

ATR0.41
Enterprise Value262.18M
Avg Vol (3 Months)273.49K
Avg Vol (10 Days)143.22K

FENC Technical Analysis Indicators

Fennec Pharmaceuticals Inc. (FENC) technical indicators as of July 9, 2026: the SMA 20 is 4.41%, SMA 50 at 9.14%, and SMA 200 at 4.48%. The RSI 14 value is 58.41, suggesting its current momentum. These technical analysis signals help assess FENC's price trends and potential future movements.

SMA 204.41%
SMA 509.14%
SMA 2004.48%
RSI 1458.41

FENC Stock Performance Overview

Fennec Pharmaceuticals Inc. (FENC) stock performance overview as of July 9, 2026: The 52-week high is $11.31 (currently -13.21% below), and the 52-week low is $5.65 (currently 83.97% above). Over the past year, FENC's performance is 31.26%, compared to the S&P 500's 5.45% change.

52-Week High11.31
52-Week High Chg-13.21%
52-Week Low5.65
52-Week Low Chg+83.97%
S&P 500 52-Week Chg5.45%

Fennec Pharmaceuticals Inc. (FENC) Historical Stock Performance

According to market data, Fennec Pharmaceuticals Inc. (FENC) stock's recent performance metrics show that over the last month, FENC is -1.99%, with a Year-to-Date (YTD) performance of -4.03%. Over the past year, the stock has seen a 31.26% change. These figures summarize FENC's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High10.9511.3111.3111.3111.3111.31
Low10.048.525.655.655.655.65
Performance-3.02%-1.99%-10.32%-12.13%+31.26%-4.03%

Industry Analysis and Valuation

According to current financial data, FENC stock's P/E (TTM) ratio is -33.57, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for FENC, including P/S (5.78), P/B (9.40), and P/FCF (-51.01), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationFENCSector MedianIndustry AvgS&P 500
P/E (TTM)-33.57-1.22-194.0232.59
P/S (TTM)5.783.68466.985.98
P/B (TTM)9.42.7411.225.25
P/FCF (TTM)-51.01-10.99-613.729.69

Frequently Asked Questions

How is FENC price-to-earnings ratio currently?
FENC has a current P/E ratio of -33.57
How are FENC's price-to-sale and price-to-book ratios?
The FENC stock has a trailing twelve month price-to sales (P/S) ratio of 5.78 while its price-to-book (P/B) value is 9.4.
Is Fennec Pharmaceuticals Inc.'s price-to-cashflow ratio high or low?
FENC's price-to-free-cashflow (P/FCF) ratio is -51.01, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for FENC?
Based on FENC's recent bid, its distance from 20 days simple moving average is 4.41%. It is 9.14% apart from 50 days simple moving average, and it is 4.48% apart from 200 days simple moving average.
What is the 52-week price range for FENC?
The 52-week high for FENC is $11.31 which is -13.21% away from the current price level whereas the distance of that from the 52-week low of $5.65 stands at 83.97%.
An overview of FENC's stock performance: how did it fare?
The performance of FENC stock was not encouraging with most of its significant price indicators in red. Fennec Pharmaceuticals Inc.(NASDAQ: FENC) shares have moved upward +0.59% or $0.06 in the latest trading session and have lost -4.03% year-to-date (YTD). The stock has gained nearly 31.26% over the past year. After moving -10.32% over the trailing 3-month period, the stock is -12.13% lower in the 6-month period. Looking at its performance over the shorter term, it'slost -3.02% a week and -1.99% a month.
What is FENC's 14-day relative strength index (RSI)?
The current 14-day RSI for FENC stock is 58.41. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For FENC, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Fennec Pharmaceuticals Inc. (FENC) has a 14-day ATR of 0.41.
What is FENC's current enterprise value?
After closing at $10.25 with 28.58M of its shares outstanding, the current enterprise value of FENC is roughly 262.18M.
Over the past year, how has the stock price of FENC changed?
Fennec Pharmaceuticals Inc. (NASDAQ: FENC) is up 31.26% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 5.45%. FENC stock price is also down -4.03% on its value in year-to-date trading.
What is the average trading volume for FENC shares?
The number outstanding shares of FENC is 28.58M, and of these 74.74% shares are freely available for trading. On average, FENC stock has traded 143.22K shares per day for the past 10 days. A total of 97.17K shares changed hands during the last trading session with the average session volume of 274.97K shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph